49040 Federal Register / Vol. 86, No. 167 / Wednesday, September 1, 2021 / Notices 

Contact Person: Eliane Lazar-Wesley, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, Division of Extramural 

Activities, 6001 Executive Boulevard, Room 

8339, MSC 9670, Bethesda, MD 20892–8401, 

301–496–8683, el6r@nih.gov. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel; P50 

Clinical Research Center Grant Review. 

Date: November 4, 2021. 

Time: 12:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Andrea B. Kelly, Ph.D., 

Scientific Review Officer, National Institute 

on Deafness and Other Communication 

Disorders, National Institutes of Health, 6001 

Executive Boulevard, Room 8351, Bethesda, 

MD 20892, (301) 451–6339, kellya2@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.173, Biological Research 

Related to Deafness and Communicative 

Disorders, National Institutes of Health, HHS) 

Dated: August 27, 2021. 

Miguelina Perez, 

Program Analyst, Office Federal Advisory 

Committee Policy. 

[FR Doc. 2021–18854 Filed 8–31–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

Electronic Nicotine Delivery Systems 

(ENDS): Population, Clinical and Applied 

Prevention Research. 

Date: October 1, 2021. 

Time: 11:30 a.m. to 7:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892, (Virtual Meeting). 

Contact Person: Pamela Jeter, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 10J08, 

Bethesda, MD 20892, (301) 435–2591, 

pamela.jeter@nih.gov. 

Name of Committee: Risk, Prevention and 

Health Behavior Integrated Review Group; 

Biobehavioral Medicine and Health 

Outcomes Study Section. 

Date: October 4–5, 2021. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Mark A. Vosvick, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3110, 

Bethesda, MD 20892, (301) 402–4128, 

mark.vosvick@nih.gov. 

Name of Committee: Biobehavioral and 

Behavioral Processes Integrated Review; 

Group Motor Function, Speech and 

Rehabilitation Study Section. 

Date: October 4–5, 2021. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Biao Tian, Ph.D., Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 3166, MSC 7848, Bethesda, MD 

20892, 301–402–4411, tianbi@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: August 27, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–18859 Filed 8–31–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development Initial 

Review Group; Obstetrics and Maternal-Fetal 

Biology Study Section. 

Date: October 29, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, National Institutes of Health, 

6710B Rockledge Drive, Room 2131B, 

Bethesda, MD 20892 (Video-Assisted 

Meeting). 

Contact Person: Luis E. Dettin, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, National Institutes of Health, 

6710B Rockledge Drive, Room 2131B, 

Bethesda, MD 20892, (301) 827–8231, 

Luis.Dettin@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: August 26, 2021. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–18845 Filed 8–31–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 30-Day 

Comment Request Electronic 

Individual Development Plan (eIDP) 

(National Eye Institute); Correction 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice; correction. 

SUMMARY: The Department of Health and 

Human Services, National Institutes of 

Health published a Notice in the 

Federal Register on August 26, 2021. 

That Notice requires a correction in the 

SUPPLEMENTARY INFORMATION section. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 86, No. 167 / Wednesday, September 1, 2021 / Notices 49041 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

FOR FURTHER INFORMATION CONTACT: To 

obtain a copy of the data collection 

plans and instruments, submit 

comments in writing, or request more 

information on the proposed project, 

contact: Dr. Cesar E. Perez-Gonzalez, 

Training Director, Office of the 

Scientific Director, National Eye 

Institute, NIH, Building 31, Room 6A22, 

MSC 0250, Bethesda, Maryland 20892 

or call non-toll-free number (301) 451– 

6763 or Email your request, including 

your address to: cesarp@nei.nih.gov. 

Formal requests for additional plans and 

instruments must be requested in 

writing. 

SUPPLEMENTARY INFORMATION: 

Correction 

In the Federal Register of August 26, 2021, 

in FR Doc. 2021–18393, on page 47652, as 

found within the SUPPLEMENTARY

INFORMATION section, within the Estimated 

Annualized Burden Hours table for the 

Number of Responses per Respondent 

column total currently reads ‘‘150’’ and is 

corrected to read: ‘‘450’’. 

Daniel R. Hernandez, 

NIH Federal Register Certifying Official, 

National Institutes of Health. 

[FR Doc. 2021–18812 Filed 8–31–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases, 

Special Emphasis Panel; Time Sensitive 

Obesity. 

Date: September 28, 2021. 

Time: 3:00 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892 (Video 

Meeting). 

Contact Person: Michele L. Barnard, Ph.D., 

Scientific Review Officer, Review Branch, 

Division of Extramural Activities, NIDDK, 

National Institutes of Health, Room 7353, 

6707 Democracy Boulevard, Bethesda, MD 

20892–2542, (301) 594–8898, barnardm@

extra.niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: August 27, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–18860 Filed 8–31–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

In compliance with Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995 concerning 

opportunity for public comment on 

proposed collections of information, the 

Substance Abuse and Mental Health 

Services Administration (SAMHSA) 

will publish periodic summaries of 

proposed projects. To request more 

information on the proposed projects or 

to obtain a copy of the information 

collection plans, call the SAMHSA 

Reports Clearance Officer at (240) 276– 

0361. 

Comments are invited on: (a) Whether 

the proposed collections of information 

are necessary for the proper 

performance of the functions of the 

agency, including whether the 

information shall have practical utility; 

(b) the accuracy of the agency’s estimate 

of the burden of the proposed collection 

of information; (c) ways to enhance the 

quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Proposed Project: Treatment Episode 

Data Set (TEDS) (OMB No. 0930– 

0335)—Extension 

The Substance Abuse and Mental 

Health Services Administration 

(SAMHSA) is requesting an extension to 

collect the Treatment Episode Data Set 

(TEDS) data collection (OMB No. 0930– 

0335), which expires on April 30, 2022. 

TEDS is a compilation of client-level 

substance use treatment admission and 

discharge data submitted by states on 

clients treated in facilities that receive 

state funds. SAMHSA is also requesting 

an extension to collect the client-level 

mental health admission and update/ 

discharge data (MH–TEDS/MH–CLD) 

submitted by states on clients treated in 

facilities that receive state funds (also 

OMB No. 0930–0335). 

TEDS/MH–TEDS/MH–CLD data are 

collected to obtain information on the 

number of admissions and updates/ 

discharges at publicly funded substance 

use treatment and mental health 

services facilities and on the 

characteristics of clients receiving 

services at those facilities. 

TEDS/MH–TEDS/MH–CLD also 

monitor trends in the demographic, 

substance use, and mental health 

characteristics of admissions. In 

addition, several of the data elements 

used to calculate performance measures 

for the Substance Abuse Block Grant 

(SABG) and Mental Health Block Grant 

(MHBG) applications are collected 

through the TEDS/MH–TEDS/MH–CLD. 

Most states collect the TEDS/MH– 

TEDS/MH–CLD data elements from 

their treatment providers for their own 

administrative purposes and are able to 

submit a cross-walked extract of their 

data to TEDS/MH–TEDS/MH–CLD. No 

changes are expected in the TEDS/MH– 

TEDS/MH–CLD data elements that are 

collected. 

Estimated annual burden for the 

separate TEDS/MH–TEDS/MH–CLD 

activities is as follows: 

Type of activity 

Number of 

respondents 

(states/ 

jurisdictions) 

Responses 

per 

respondent 

Total 

responses 

Hours per 

response 

Total burden 

hours 

TEDS Admission Data ......................................................... 52 4 208 6.25 1,300 


khammond on DSKJM1Z7X2PROD with NOTICES